ALONGI, FILIPPO
 Distribuzione geografica
Continente #
NA - Nord America 16.990
EU - Europa 8.375
AS - Asia 8.286
SA - Sud America 2.181
AF - Africa 185
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 14
Totale 36.047
Nazione #
US - Stati Uniti d'America 16.758
SG - Singapore 3.038
CN - Cina 2.224
DE - Germania 2.016
BR - Brasile 1.831
PL - Polonia 1.472
UA - Ucraina 1.360
HK - Hong Kong 1.265
RU - Federazione Russa 921
GB - Regno Unito 800
VN - Vietnam 680
IT - Italia 442
FR - Francia 386
TR - Turchia 372
IE - Irlanda 333
FI - Finlandia 284
IN - India 151
AR - Argentina 130
SE - Svezia 120
BD - Bangladesh 104
CA - Canada 103
ID - Indonesia 78
IQ - Iraq 72
MX - Messico 71
EC - Ecuador 53
ZA - Sudafrica 52
CO - Colombia 50
AT - Austria 44
PK - Pakistan 39
NL - Olanda 36
SA - Arabia Saudita 36
JP - Giappone 32
MA - Marocco 32
BE - Belgio 31
ES - Italia 28
VE - Venezuela 27
KE - Kenya 23
UZ - Uzbekistan 23
PE - Perù 22
PY - Paraguay 22
CL - Cile 20
EG - Egitto 17
IL - Israele 17
CZ - Repubblica Ceca 16
JO - Giordania 16
TN - Tunisia 16
EU - Europa 15
AU - Australia 13
JM - Giamaica 13
GR - Grecia 12
AE - Emirati Arabi Uniti 11
BO - Bolivia 11
CH - Svizzera 11
CR - Costa Rica 11
KZ - Kazakistan 11
NP - Nepal 11
TW - Taiwan 11
UY - Uruguay 11
AZ - Azerbaigian 10
DZ - Algeria 10
LB - Libano 10
LT - Lituania 10
OM - Oman 10
ET - Etiopia 9
TT - Trinidad e Tobago 9
BH - Bahrain 8
DO - Repubblica Dominicana 8
PT - Portogallo 8
NG - Nigeria 7
PH - Filippine 7
AL - Albania 6
IR - Iran 6
KG - Kirghizistan 6
MY - Malesia 6
BG - Bulgaria 5
MU - Mauritius 5
PA - Panama 5
BY - Bielorussia 4
CI - Costa d'Avorio 4
GY - Guiana 4
HN - Honduras 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
SN - Senegal 4
AM - Armenia 3
DK - Danimarca 3
GE - Georgia 3
HU - Ungheria 3
KH - Cambogia 3
MD - Moldavia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
BA - Bosnia-Erzegovina 2
EE - Estonia 2
GA - Gabon 2
GT - Guatemala 2
KR - Corea 2
LK - Sri Lanka 2
LY - Libia 2
Totale 36.019
Città #
Fairfield 2.569
Ashburn 1.506
Singapore 1.502
Warsaw 1.467
Hong Kong 1.255
Woodbridge 1.210
Jacksonville 1.066
Seattle 961
Cambridge 926
Houston 897
Wilmington 834
Princeton 611
The Dalles 582
Dallas 581
Chandler 564
Beijing 464
Ann Arbor 411
San Jose 337
Dublin 325
Lauterbourg 309
New York 307
Istanbul 300
Helsinki 235
Nanjing 235
Ho Chi Minh City 228
Los Angeles 227
Des Moines 171
Moscow 150
Dearborn 136
Redondo Beach 130
Hanoi 129
San Diego 124
São Paulo 124
Buffalo 115
Council Bluffs 101
Nürnberg 100
London 91
Nanchang 89
Changsha 83
Dong Ket 74
Chicago 64
Munich 56
Jinan 55
Rio de Janeiro 54
Hebei 53
Shanghai 53
Jiaxing 51
Orem 48
Shenyang 46
Frankfurt am Main 44
San Francisco 44
Nuremberg 43
Santa Clara 43
Brescia 41
Brooklyn 41
Brasília 38
Belo Horizonte 37
Milan 37
Tianjin 36
Curitiba 35
Phoenix 33
Boardman 32
Jakarta 31
Johannesburg 31
Brussels 29
Kunming 29
Montreal 29
Orange 29
Poplar 29
Kocaeli 28
Hangzhou 27
Tokyo 27
Kilburn 26
Guangzhou 25
North York 25
Rome 25
Westminster 25
Atlanta 24
Zhengzhou 24
Chennai 23
Dhaka 23
Haiphong 23
Lappeenranta 23
Romola 23
Denver 22
Fortaleza 22
Tashkent 22
Mexico City 21
Nairobi 21
Porto Alegre 21
Salt Lake City 21
Baghdad 20
Da Nang 20
Kyiv 20
Stockholm 20
Turku 20
Goiânia 19
Salvador 19
Vienna 19
Ankara 18
Totale 23.413
Nome #
1.5 T MR-guided and daily adapted SBRT for prostate cancer: Feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment 390
1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients 289
Dose-volumerelated dysphagia after constrictor muscles definition in head and neck cancer intensitymodulated radiation treatment 265
Weekly Cisplatin and Volumetric-Modulated Arc Therapy With Simultaneous Integrated Boost for Radical Treatment of Advanced Cervical Cancer in Elderly Patients: Feasibility and Clinical Preliminary Results 263
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: The point of view of the radiation oncologist 257
1.5 T MR-Guided Daily Adapted SBRT on Lymph Node Oligometastases from Prostate Cancer 251
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: Role of local treatments 249
SBRT and extreme hypofractionation: A new era in prostate cancer treatments? 247
Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique 244
Postoperative breast radiotherapy after neoadjuvant chemotherapy: which uncertainties still remain? 243
Dose variability in different lymph node levels during locoregional breast cancer irradiation: the impact of deep-inspiration breath hold 240
Radiotherapy in patients with connective tissue diseases 236
Real-time intra-fraction motion management in breast cancer radiotherapy: Analysis of 2028 treatment sessions 231
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 218
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 206
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 205
MR-guidance in clinical reality: Current treatment challenges and future perspectives 204
(Ga-68)-PSMA-PET/CT for the detection of postoperative prostate cancer recurrence: Possible implications on treatment volumes for radiation therapy 198
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 188
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial 184
ONE SHOT - single shot radiotherapy for localized prostate cancer: Study protocol of a single arm, multicenter phase I/II trial 182
An update on radiation therapy in head and neck cancers 181
Radiotherapy in patients with HIV: current issues and review of the literature 180
Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO) 180
Mastectomy or breast-conserving therapy for early breast cancer in real-life clinical practice: outcome comparison of 7565 cases 180
Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study 178
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 173
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 171
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective 169
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer? 168
Intra-fraction and Inter-fraction analysis of a dedicated immobilization device for intracranial radiation treatment 168
Role of radiosurgery/stereotactic radiotherapy in oligometastatic disease: Brain oligometastases 164
Re: Giorgio Gandaglia, Alberto Briganti, Noel Clarke, et al. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.01.039. 162
GUROPA survey: genito-urinary radiation oncology prescription attitudes 162
[11C]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 162
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 160
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 159
11C choline PET guided salvage radiotherapy with volumetric modulation arc therapy and hypofractionation for recurrent prostate cancer after HIFU failure: preliminary results of tolerability and acute toxicity 159
A plethora of therapeutic opportunities for elderly patients with cancer: A nontrivial choice 159
What is changing in radiotherapy for the treatment of locally advanced nonsmall cell lung cancer patients? A review 158
Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system 158
18F-sodium fluoride PET-CT for the assessment of brain metastasis from lung Adenocarcinoma 157
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 155
Optical Surface Scanning for Patient Positioning in Radiation Therapy: A Prospective Analysis of 1902 Fractions 153
Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer 149
Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer. 148
Radiation dose-response relationship for risk of coronary heart disease in survivors of hodgkin lymphoma 148
Extreme hypofractionation for early prostate cancer: Biology meets technology 147
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis 147
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 146
Interplay effects between dose distribution quality and positioning accuracy in total marrow irradiation with volumetric modulated arc therapy 146
Stereotactic precision and conventional radiotherapy evaluation (SPACE)-Trial for medically inoperable Stage I NSCLC: A lost opportunity? 145
Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey 145
Radiotherapy in the multidisciplinary treatment of liver cancer: a survey on behalf of the Italian Association of Radiation Oncology 143
Choline-PET in prostate cancer management: The point of view of the radiation oncologist 140
Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature. 140
Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature 139
Cancer Therapy combining high-intensity focused ultrasound and megavoltage radiation 139
Technical Note: Correction for intra-chamber dose gradients in reference dosimetry of flattening-filter-free MV photon beams 139
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 139
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 139
Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study. 138
From radiobiology to technology: What is changing in radiotherapy for prostate cancer 138
Watch-and-wait versus surgical resection for patients with rectal cancer 137
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 137
Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: Report of dosimetric and early clinical results in oligometastatic patients 137
Personalized - Not omitted - Radiation oncology for breast cancer 137
Neuroendocrine carcinoma of the breast: Current evidence and future perspectives 136
Cone-beam computed tomography in lung stereotactic ablative radiation therapy: Predictive parameters of early response 136
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies 136
Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: Dosimetric impact of an increased near-maximum target dose and of a rectal spacer 136
Prostate cancer as a paradigm of multidisciplinary approach? highlights from the italian young radiation oncologist meeting 135
Impact of weight loss in patients with head and neck carcinoma undergoing radiotherapy: Is it an underestimated phenomenon A radiation oncologist's perspective 135
Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost 135
Toxicity of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: A potential comparison bias 134
Organ sparing and clinical outcome with step-and-shoot IMRT for head and neck cancer: a mono-institutional experience 134
Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy 134
Crowd knowledge based community in radiotherapy: In response to Yartev et al 133
Stereotactic radiosurgery for patients with brain metastases 133
Predictors of mucositis in oropharyngeal and oral cavity cancer in patients treated with volumetric modulated radiation treatment: A dose-volume analysis 133
Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity 133
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists. 132
Stereotactic radiosurgery for intracranial metastases: Linac-based and gamma-dedicated unit approach 132
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 129
Current radiotherapy techniques in NSCLC: challenges and potential solutions 129
Consolidative local therapy in oligometastatic patients 128
Stereotactic body radiotherapy with flattening filter-free beams for prostate cancer: assessment of patient-reported quality of life 128
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial. 128
Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for brain metastases: a dosimetric volumetric-modulated arc therapy study 128
Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy 128
The BUONGIORNO project: Burnout syndrome among young italian radiation oncologists 128
Impact of surface-guided positioning on the use of portal imaging and initial set-up duration in breast cancer patients 128
Stability and reproducibility of 6013 deep inspiration breath-holds in left-sided breast cancer 128
Impact of 18F-choline PET/CT in the decision-making strategy of treatment volumes in definitive prostate cancer volumetric modulated radiation therapy 127
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani) 126
Spinal metastases: Is stereotactic body radiation therapy supported by evidences? 126
Could single-high-dose radiotherapy be considered the new frontier of stereotactic ablative radiation therapy? 126
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 126
Three-dimensional conformal versus intensity modulated radiotherapy in breast cancer treatment: is necessary a medical reversal? 126
Sequential boost in neoadjuvant irradiation for T3N0-1 rectal cancer: Long-term results from a single-center experience 125
Totale 16.380
Categoria #
all - tutte 187.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.289


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.436 0 0 0 0 0 0 0 0 0 720 376 340
2021/20222.185 164 407 63 144 18 155 121 215 117 201 158 422
2022/20231.840 359 34 46 145 125 501 6 182 263 25 73 81
2023/20242.079 121 56 120 165 84 300 65 65 622 56 41 384
2024/20254.931 21 29 50 567 658 373 385 183 583 483 1.019 580
2025/20269.511 860 1.491 1.408 1.724 648 544 1.184 375 584 693 0 0
Totale 36.524